|
|
Volumn 339, Issue 7722, 2009, Pages 664-665
|
|
Is rate more important than rhythm in treating atrial fibrillation? Yes or No
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMIODARONE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIGOXIN;
ANTIARRHYTHMIC AGENT;
CARDIAC PATIENT;
CARDIOVERSION;
COST EFFECTIVENESS ANALYSIS;
DISEASE EXACERBATION;
DRUG WITHDRAWAL;
ELECTROCARDIOGRAPHY MONITORING;
HEART ATRIOVENTRICULAR NODE;
HEART ATRIUM CONTRACTILITY;
HEART ATRIUM FIBRILLATION;
HEART RATE;
HUMAN;
MORTALITY;
NOTE;
PATIENT SELECTION;
PRIORITY JOURNAL;
QUALITY OF LIFE;
SINUS NODE;
SINUS RHYTHM;
STROKE;
THROMBOSIS PREVENTION;
ARTICLE;
COST BENEFIT ANALYSIS;
THROMBOEMBOLISM;
TREATMENT OUTCOME;
ANTI-ARRHYTHMIA AGENTS;
ATRIAL FIBRILLATION;
COST-BENEFIT ANALYSIS;
ELECTRIC COUNTERSHOCK;
HEART RATE;
HUMANS;
QUALITY OF LIFE;
STROKE;
THROMBOEMBOLISM;
TREATMENT OUTCOME;
|
|
EID: 70349238678
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.b3173 Document Type: Note |
|
Times cited : (7)
|
|
References (0)
|
